Discounted Cash Flow (DCF) Analysis Unlevered
Bruush Oral Care Inc. (BRSH)
$0.1635
-0.00 (-0.30%)
All numbers are in Millions, Currency in USD
Operating Data
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 0.21 | 0.90 | 2.62 | 2.63 | 7.25 | 19.94 | 54.90 | 151.10 | 415.90 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | |||||||||
| EBITDA | -1.36 | -8.33 | -5.47 | -10.49 | -39.64 | -109.11 | -300.32 | -826.62 | -2,275.28 |
| EBITDA (%) | |||||||||
| EBIT | -1.36 | -8.33 | -5.48 | -10.51 | -39.67 | -109.19 | -300.55 | -827.28 | -2,277.08 |
| EBIT (%) | |||||||||
| Depreciation | - | - | 0.01 | 0.02 | 0.03 | 0.09 | 0.24 | 0.65 | 1.79 |
| Depreciation (%) |
Balance Sheet Data
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 0.18 | 0.69 | 0.02 | 0.09 | 3.05 | 8.39 | 23.09 | 63.56 | 174.95 |
|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | |||||||||
| Account Receivables | 0.01 | 0.08 | 0.20 | 0.20 | 0.55 | 1.52 | 4.19 | 11.53 | 31.73 |
| Account Receivables (%) | |||||||||
| Inventories | 0.60 | 1.18 | 0.83 | 0.24 | 8.33 | 22.94 | 63.13 | 173.76 | 478.28 |
| Inventories (%) | |||||||||
| Accounts Payable | 0.26 | 0.24 | 2.30 | 0.91 | 4.94 | 13.61 | 37.45 | 103.08 | 283.74 |
| Accounts Payable (%) | |||||||||
| Capital Expenditure | - | -0 | -0.01 | -0 | -0.02 | -0.05 | -0.14 | -0.38 | -1.04 |
| Capital Expenditure (%) |
Weighted Average Cost Of Capital
| Share price | $ 0.1,635 |
|---|---|
| Beta | 0.000 |
| Diluted Shares Outstanding | 7.34 |
| Cost of Debt | |
| Tax Rate | 63.74 |
| After-tax Cost of Debt | 1.81% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 4.110 |
| Total Debt | - |
| Total Equity | 1.20 |
| Total Capital | 1.20 |
| Debt Weighting | 0.00 |
| Equity Weighting | 100.00 |
| Wacc |
Build Up Free Cash
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 0.21 | 0.90 | 2.62 | 2.63 | 7.25 | 19.94 | 54.90 | 151.10 | 415.90 |
|---|---|---|---|---|---|---|---|---|---|
| EBITDA | -1.36 | -8.33 | -5.47 | -10.49 | -39.64 | -109.11 | -300.32 | -826.62 | -2,275.28 |
| EBIT | -1.36 | -8.33 | -5.48 | -10.51 | -39.67 | -109.19 | -300.55 | -827.28 | -2,277.08 |
| Tax Rate | 0.00% | 0.00% | 0.00% | 63.74% | 15.94% | 15.94% | 15.94% | 15.94% | 15.94% |
| EBIAT | -1.36 | -8.33 | -5.48 | -3.81 | -33.35 | -91.79 | -252.66 | -695.45 | -1,914.21 |
| Depreciation | - | - | 0.01 | 0.02 | 0.03 | 0.09 | 0.24 | 0.65 | 1.79 |
| Accounts Receivable | - | -0.07 | -0.12 | -0 | -0.35 | -0.97 | -2.67 | -7.34 | -20.20 |
| Inventories | - | -0.58 | 0.35 | 0.59 | -8.09 | -14.60 | -40.19 | -110.63 | -304.52 |
| Accounts Payable | - | -0.02 | 2.06 | -1.39 | 4.03 | 8.66 | 23.84 | 65.63 | 180.65 |
| Capital Expenditure | - | -0 | -0.01 | -0 | -0.02 | -0.05 | -0.14 | -0.38 | -1.04 |
| UFCF | -1.36 | -9 | -3.19 | -4.60 | -37.75 | -98.67 | -271.58 | -747.51 | -2,057.52 |
| WACC | |||||||||
| PV UFCF | -37.75 | -94.77 | -250.56 | -662.43 | -1,751.36 | ||||
| SUM PV UFCF | -2,686.45 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 4.11 |
| Free cash flow (t + 1) | -2,098.68 |
| Terminal Value | -99,463.27 |
| Present Value of Terminal Value | -81,320.59 |
Intrinsic Value
| Enterprise Value | -84,007.04 |
|---|---|
| Net Debt | -0.07 |
| Equity Value | -84,006.96 |
| Shares Outstanding | 7.34 |
| Equity Value Per Share | -11,439.38 |